Hjem › Medulloblastom › Texas
Medulloblastom kliniske forsøg i Texas
8 studier for Medulloblastom søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
RekruttererFase 2
59 Months · Alle køn · Opdateret 15. sep. 2026 · NCT05535166Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Dell Children's Medical Group SFC-HEM/ONC, Austin
RekruttererFase 2
Op til 19 år · Alle køn · Opdateret 10. sep. 2026 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
RekruttererFase 1
36 Months – 22 Years · Alle køn · Opdateret 4. sep. 2026 · NCT03911388Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
- Baylor College of Medicine, Houston
- MD Anderson Cancer Center, Houston
RekruttererObservationsstudie
Alder 3 til 50 · Alle køn · Opdateret 1. sep. 2026 · NCT07242963Digoxin Medulloblastoma Study
- UT Southwestern, Dallas
RekruttererFase 2
12 Months – 30 Years · Alle køn · Opdateret 26. aug. 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- og 4 flere
RekruttererFase 3
Alder 4 til 21 · Alle køn · Opdateret 25. aug. 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Texas Children's Hospital, Houston
RekruttererFase 2
Alder 3 til 39 · Alle køn · Opdateret 24. aug. 2026 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Dell Children's Blood and Cancer Center, Austin
RekruttererFase 2
Op til 21 år · Alle køn · Opdateret 12. aug. 2026 · NCT04696029Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.